Lansforsakringar Fondforvaltning AB publ Purchases 1,264 Shares of Axon Enterprise, Inc $AXON

Lansforsakringar Fondforvaltning AB publ lifted its position in Axon Enterprise, Inc (NASDAQ:AXON) by 5.5% during the 1st quarter, HoldingsChannel reports. The firm owned 24,263 shares of the biotechnology company’s stock after buying an additional 1,264 shares during the period. Lansforsakringar Fondforvaltning AB publ’s holdings in Axon Enterprise were worth $10,304,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in AXON. Rockefeller Capital Management L.P. increased its position in shares of Axon Enterprise by 53.2% in the fourth quarter. Rockefeller Capital Management L.P. now owns 11,518 shares of the biotechnology company’s stock worth $6,542,000 after purchasing an additional 4,002 shares during the last quarter. Legal & General Group Plc lifted its position in Axon Enterprise by 1.3% during the fourth quarter. Legal & General Group Plc now owns 426,533 shares of the biotechnology company’s stock valued at $242,241,000 after purchasing an additional 5,419 shares during the last quarter. Eurizon Capital SGR S.p.A. purchased a new position in Axon Enterprise in the 4th quarter worth approximately $13,116,000. Wealth Enhancement Advisory Services LLC grew its stake in Axon Enterprise by 93.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 23,365 shares of the biotechnology company’s stock worth $13,270,000 after buying an additional 11,262 shares in the last quarter. Finally, Teamwork Financial Advisors LLC increased its holdings in shares of Axon Enterprise by 40.5% in the 4th quarter. Teamwork Financial Advisors LLC now owns 25,352 shares of the biotechnology company’s stock worth $14,398,000 after buying an additional 7,307 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $593.96 on Thursday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $885.91. The firm has a market cap of $47.87 billion, a PE ratio of 238.54, a price-to-earnings-growth ratio of 11.44 and a beta of 1.38. The business has a 50 day moving average price of $429.96 and a 200-day moving average price of $481.36.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. The company had revenue of $807.35 million during the quarter, compared to analyst estimates of $778.90 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. Axon Enterprise’s revenue for the quarter was up 33.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.47 earnings per share. Equities research analysts predict that Axon Enterprise, Inc will post 1.63 earnings per share for the current year.

Key Headlines Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: News that President Trump reportedly bought up to $5 million of Axon stock, followed by an ICE request for a potential $220 million TASER contract, has sparked speculation that demand for Axon’s public-safety equipment could accelerate. Trump bought up to $5M in Axon stock. ICE sought a $220M Taser deal weeks later
• Positive Sentiment: Axon’s latest results also remain a support for the stock, with first-quarter revenue up 33.7% year over year and earnings slightly ahead of expectations, reinforcing the company’s growth narrative. Axon Enterprise jumps as investors react to disclosure-linked contract narrative and strong operating momentum
• Positive Sentiment: Axon’s Software & Services business is also gaining traction, with rising digital evidence demand, network users, and Dedrone growth helping support investor confidence in longer-term recurring revenue. AXON Gains From Strength in Software & Services Unit: Can the Momentum Sustain?
• Positive Sentiment: Several analyst views remain constructive, including recent buy/overweight reiterations and price targets well above recent trading levels. Northland Securities Reaffirms Their Buy Rating on Axon Enterprise (AXON)

Insider Activity

In related news, insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $400.00, for a total transaction of $800,000.00. Following the completion of the transaction, the insider directly owned 52,813 shares of the company’s stock, valued at $21,125,200. This trade represents a 3.65% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Patrick W. Smith sold 20,000 shares of Axon Enterprise stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total transaction of $10,000,000.00. Following the transaction, the chief executive officer owned 3,060,997 shares of the company’s stock, valued at $1,530,498,500. The trade was a 0.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 48,989 shares of company stock worth $24,090,083. Company insiders own 4.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on AXON. UBS Group lowered their price objective on shares of Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a research report on Thursday, May 7th. Morgan Stanley set a $600.00 target price on Axon Enterprise in a research note on Thursday, May 7th. Barclays lowered their price target on Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating on the stock in a research report on Friday, May 8th. Citizens Jmp reiterated a “market outperform” rating and issued a $700.00 price objective on shares of Axon Enterprise in a report on Thursday, June 25th. Finally, Piper Sandler reiterated an “overweight” rating and set a $674.00 price objective on shares of Axon Enterprise in a research report on Monday, June 15th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $712.75.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.